carnitine and celecoxib

carnitine has been researched along with celecoxib in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (16.67)	29.6817
2010's	5 (83.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR	1
Antoni, G; Astara, G; Cau, MC; Dessì, M; Macciò, A; Madeddu, C; Mantovani, G; Mela, Q; Montaldo, L; Mura, M; Panzone, F; Serpe, R; Tanca, FM	1
Cau, MC; Floris, C; Gramignano, G; Macciò, A; Madeddu, C; Mantovani, G; Mulas, C; Panzone, F; Sanna, E	1
Gramignano, G; Macciò, A; Madeddu, C	1

Trials

2 trial(s) available for carnitine and celecoxib

Article	Year
Randomized phase III clinical trial of a combined treatment with carnitine + celecoxib ± megestrol acetate for patients with cancer-related anorexia/cachexia syndrome. Clinical nutrition (Edinburgh, Scotland), 2012, Volume: 31, Issue:2 Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Anorexia; Appetite; Cachexia; Carnitine; Celecoxib; Combined Modality Therapy; Drug Combinations; Endpoint Determination; Female; Humans; Male; Megestrol Acetate; Middle Aged; Neoplasms; Patient Compliance; Pyrazoles; Quality of Life; Sulfonamides; Treatment Outcome	2012
A randomized phase III clinical trial of a combined treatment for cachexia in patients with gynecological cancers: evaluating the impact on metabolic and inflammatory profiles and quality of life. Gynecologic oncology, 2012, Volume: 124, Issue:3 Topics: Adult; Aged; Antioxidants; Cachexia; Carnitine; Celecoxib; Female; Genital Neoplasms, Female; Humans; Inflammation; Megestrol Acetate; Middle Aged; Prospective Studies; Pyrazoles; Quality of Life; Sulfonamides; Treatment Outcome	2012

Article

Year

Randomized phase III clinical trial of a combined treatment with carnitine + celecoxib ± megestrol acetate for patients with cancer-related anorexia/cachexia syndrome.

Clinical nutrition (Edinburgh, Scotland), 2012, Volume: 31, Issue:2

Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Anorexia; Appetite; Cachexia; Carnitine; Celecoxib; Combined Modality Therapy; Drug Combinations; Endpoint Determination; Female; Humans; Male; Megestrol Acetate; Middle Aged; Neoplasms; Patient Compliance; Pyrazoles; Quality of Life; Sulfonamides; Treatment Outcome

2012

A randomized phase III clinical trial of a combined treatment for cachexia in patients with gynecological cancers: evaluating the impact on metabolic and inflammatory profiles and quality of life.

Gynecologic oncology, 2012, Volume: 124, Issue:3

Topics: Adult; Aged; Antioxidants; Cachexia; Carnitine; Celecoxib; Female; Genital Neoplasms, Female; Humans; Inflammation; Megestrol Acetate; Middle Aged; Prospective Studies; Pyrazoles; Quality of Life; Sulfonamides; Treatment Outcome

2012

Other Studies

4 other study(ies) available for carnitine and celecoxib

Article	Year
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2). Journal of medicinal chemistry, 2008, Jun-12, Volume: 51, Issue:11 Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship	2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions. Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10 Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection	2012
Surprising results of a supportive integrated therapy in myelofibrosis. Nutrition (Burbank, Los Angeles County, Calif.), 2015, Volume: 31, Issue:1 Topics: Anemia; C-Reactive Protein; Cachexia; Carnitine; Celecoxib; Curcumin; Erythropoietin; Fatigue; Ferritins; Fever; Hepcidins; Humans; Interleukin-6; Iron; Lactoferrin; Male; Middle Aged; Oxidative Stress; Patient Compliance; Primary Myelofibrosis; Quality of Life; Reactive Oxygen Species; Recombinant Proteins; Treatment Outcome; Tumor Necrosis Factor-alpha; Weight Loss	2015